ENT Flashcards

1
Q

Define Bell’s Palsy.

A

An acute unilateral peripheral facial nerve palsy in patients for whom physical examination and history are otherwise unremarkable, consisting of deficits affecting all facial zones equally that fully evolve within 72 hours.

Facial palsy of an otherwise known aetiology (e.g., Lyme disease-associated facial palsy), or facial palsy that is progressive, waxing and waning, or affects facial zones in an uneven fashion, is not Bell’s palsy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain the aetiology / risk factors of Bell’s Palsy.

A

Risk factors:

  • Intranasal influenza vaccination
  • Pregnancy
  • URTI
  • Black or Hispanic ancestry
  • Arid or cold climate
  • Hypertension
  • Family history of Bell’s Palsy
  • Diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Summarise the epidemiology of Bell’s Palsy.

A

Most population studies generally show an annual incidence of 15–30 cases per 100,000 population. Bell palsy is thought to account for approximately 60–75% of cases of acute unilateral facial paralysis, with the right side affected 63% of the time. It can also be recurrent, with a reported recurrence range of 4–14%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Recognise the signs of Bell’s Palsy on Physical Examination.

A
  • Unilateral (rarely bilateral)
  • Involvement of all nerve branches
  • Keratoconjuncitvitis sicca (dry eye) due to loss of adequate blink function (PNS dysfunction to lacrimal gland)
  • Presence of risk factors
  • Any age from 2 to death - peak between 15 - 45 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Identify appropriate investigations for Bell’s Palsy and interpret the results.

A

Diagnosis of exclusion.

Failure to demonstrate any return of hemi-facial tone or movement within 4 to 6 months suggests an alternative diagnosis

DDx:

  • Lyme disease
  • Ascending inflammatory demyelinating polyneuropathy (AIDP or Guillian-Barre Syndrome)
  • Sarcoidosis
  • Haematogenous malignancy - e.g. leukaemia

1st Line:

  • Clinical diagnosis
  • Electroneuronography (ENoG) - if near-complete or complete facial paralysis (between 72hrs-14 days from onset) = >90% degrease in amplitude of compound muscle action potential (CMAP)
  • Needle electromyography (EMG) - absence of voluntary motor unit potentials
  • Serology for Borrelia burgdorferi - negative (Lyme disease)

2nd Line:

  • Pure-tone audiometry - normal
  • Tympanometry and stapedius reflex - absent or impaired reflex of ipsilateral efferent limb
  • MRI - gadolinium-enhanced fine-cut of facial nerve course - post-contrast enhancement of distal meatal, labyrinthine, geniculate and tympanic/mastoid segments of facial nerve, without enlargement
  • CT - fine-cut, non-enhanced = normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Identify the possible complications of Bell’s Palsy and its management.

A
  • Ulcerative keratitis - corneal ulcer
  • Blindness
  • Epiphora
  • Gustatory hyperlacrimation - Bogorad’s Syndrome or crocodile tears

(Due to aberrant regeneration of pre-ganglionic PNS fibres carried within facial nerve)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Generate a management plan for Bell’s Palsy.

A
  • Corticosteroid (Prednisolone 60mg OD oral 5 days, then reduce dose by 10mg per day after)
  • Eye protection - glasses, artificial tears, ophthalmic lubricant overnight
  • Concurrent anti-viral therapy - valaciclovir (500-1000mg BD oral 5-7 days), aciclovir (400mg 5 times a day oral 10 days)
  • Surgical decompression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define benign paroxysmal positional vertigo (BPPV).

A

A peripheral vestibular disorder that manifests as a sudden, short-lived episodes of vertigo elicited by specific head movement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain the aetiology / risk factors of benign paroxysmal positional vertigo (BPPV).

A

Most cases result from the migration of free-floating endolymph canalith particles (thought to be displaced otoconia from the utricular otolithic membrane) into the posterior (more commonly), horizontal (less commonly), or anterior (rarely) semicircular canals, rendering them sensitive to gravity

Risk factors:

  • Increasing age (>50)
  • Female age
  • Head trauma
  • Vestibular neuronitis
  • Labyrinthitis
  • Migraines
  • Inner ear surgery
  • Meniere’s disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Summarise the epidemiology of benign paroxysmal positional vertigo (BPPV).

A

One of the most common causes of vertigo.

BPPV accounted for 8% of individuals with moderate or severe dizziness/vertigo. The lifetime prevalence of BPPV was 2.4%, the 1 year prevalence was 1.6% and the 1 year incidence was 0.6%. The median duration of an episode was 2 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Recognise the presenting symptoms of benign paroxysmal positional vertigo (BPPV).

A
  • Specific provoking positions - e.g. looking up, bending down, getting up, turning head, rolling over in bed to one side

In posterior canal BPPV, patients may identify the direction of movement that precipitates an episode, thus corresponding to the affected ear.

If vertigo is not provoked by movements, then a central disorder is considered. Labyrinthitis or vestibular neuronitis can mimic BPPV, but unlike in BPPV, head movement in any plane can precipitate vertigo that will persist for days at a time.

  • Brief duration of vertigo - <30 seconds

The vertigo of other disorders lasts much longer: Meniere’s disease lasts for hours; viral labyrinthitis or vestibular neuronitis lasts for days; migraines are variable; and other central disorders can be constant.

  • Episodic vertigo - over weeks to months (POSTERIOR), over days to weeks (LATERAL)
  • Severe episodes of vertigo
  • Sudden onset of vertigo
  • Nausea, imbalance and light-headedness - can last for longer
  • Absence of associated neurological or otological symptoms - more likely to be central if hearing loss, tinnitus, aural fullness
  • Occurring after vestibular neuronitis and may co-exist with other conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Recognise the signs of benign paroxysmal positional vertigo (BPPV) on physical examination.

A
  • Presence of risk factors
  • Normal neurological examination
  • Positive Dix-Hallpike manoeuvre (POSTERIOR) or positive supine lateral head turn (LATERAL)
  • Normal otological examination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Identify appropriate investigations for benign paroxysmal positional vertigo (BPPV) and interpret the results.

A
  • Dix-Hallpike manoeuvre

The patient is seated and positioned on an examination table such that the patient’s shoulders will come to rest on the top edge of the table when supine, with the head and neck extending over the edge.

The patient’s head is turned 45° towards the ear being tested. The head is supported, and then the patient is quickly lowered into the supine position with the head extending about 30° below the horizontal while remaining turned 45° towards the ear being tested. The head is held in this position and the physician checks for nystagmus. To complete the manoeuvre, the patient is returned to a seated position and the eyes are again observed for reversal nystagmus.

The Dix-Hallpike manoeuvre can also be used to diagnose the rare anterior canal variant of BPPV, but the fast phase of nystagmus would be down-beating, opposite to posterior canal BPPV of the same ear; the torsional component would be in a similar direction, although more subtle.

  • Supine lateral head turns
  • Audiogram
  • Brain MRI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Identify appropriate investigations for benign paroxysmal positional vertigo (BPPV) and interpret the results.

A
  • Dix-Hallpike manoeuvre

The patient is seated and positioned on an examination table such that the patient’s shoulders will come to rest on the top edge of the table when supine, with the head and neck extending over the edge.

The patient’s head is turned 45° towards the ear being tested. The head is supported, and then the patient is quickly lowered into the supine position with the head extending about 30° below the horizontal while remaining turned 45° towards the ear being tested. The head is held in this position and the physician checks for nystagmus. To complete the manoeuvre, the patient is returned to a seated position and the eyes are again observed for reversal nystagmus.

The Dix-Hallpike manoeuvre can also be used to diagnose the rare anterior canal variant of BPPV, but the fast phase of nystagmus would be down-beating, opposite to posterior canal BPPV of the same ear; the torsional component would be in a similar direction, although more subtle.

Results: Vertigo with the appropriate position-provoked nystagmus response; the nystagmus and vertigo occur with 1 to 5 seconds of latency and last <30 seconds; nystagmus is torsional (rotatory) in nature, reversible with sitting, and fatigable with repeat testing; left ear BPPV has a clockwise torsional nystagmus response, while right ear BPPV has an anti-clockwise response

  • Supine lateral head turns

The clinician places the patient in a supine position and, ideally, flexes the neck 30° from horizontal to bring the lateral canals into the vertical plane of gravity. However, it is sufficient and more usual to simply lay the patient flat on his or her back.

The head is then rotated to one side, left for a minute, and then rotated to the opposite side.

Similar to the Dix-Hallpike manoeuvre, a positive test is noted when the patient experiences vertigo with nystagmus.

Results: Horizontal nystagmus without a torsional (rotatory) component; apogeotropic nystagmus (away from the ground) indicates cupulolithiasis, and geotropic (towards the ground) nystagmus indicates canalithiasis; the side with the stronger response corresponds to the affected canal in canalithiasis, and the weaker response corresponds to the affected canal in cupulolithiasis

  • Audiogram - normal in primary BPPV, can be abnormal in secondary BPPV (e.g. Meniere’s & labyrinthitis = sensorineural hearing loss)
  • Brain MRI - central condition finding that may mimic BPPV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define infectious mononucleosis.

A

A clinical syndrome most commonly caused by Epstein-Barr virus (EBV) infection in 80-90% of cases.

Mononucleosis syndrome used when the syndrome is caused by a non-EBV aetiology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain the aetiology / risk factors of infectious mononucleosis.

A

Risk factors:

  • Kissing
  • Sexual behaviour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Summarise the epidemiology of infectious mononucleosis.

A

More than 90 percent of adults worldwide show serologic evidence of Epstein Barr virus infection.

Most common time to develop clinical infectious mononucleosis: Freshman year in college.

Incubation period: 4-8 weeks.

18
Q

Recognise the presenting symptoms of infectious mononucleosis.

A
  • Adolescents and young adults
  • Febrile illness
  • Sore throat
  • Enlarged lymph nodes
  • Malaise
19
Q

Recognise the signs of infectious mononucleosis on physical examination.

A

TRIAD: Fever, Pharyngitis & Lymphadenopathy

+ atypical lymphocytosis
+ positive heterophile antibodies test
+ positive serological test for antibodies against EBV

Other Rarer Signs:

  • Splenomegaly
  • Rash
  • Signs of hepatitis - hepatomegaly, jaundice
  • Myalgia
20
Q

Identify appropriate investigations for infectious mononucleosis and interpret the results.

A

TRIAD: Fever, Pharyngitis & Lymphadenopathy

+ atypical lymphocytosis
+ positive heterophile antibodies test
+ positive serological test for antibodies against EBV

1st Line:

  • FBC - lymphocytosis, atypical lymphocytosis
  • Heterophile antibodies - positive
  • EBV-specific antibodies - positive for VCA-IgM, VCA-IgG, EA, EBV, EBNA
  • LFTs - elevated transaminases (transient, mild)

2nd Line:

  • Real-time PCR - EBV DNA detection
  • Abdominal US Scan - Splenomegaly
  • CT Abdo - Splenic rupture (haemodynamically stable patient when rupture is suspected)
21
Q

Generate a management plan for infectious mononucleosis.

A
  • Supportive care - paracetamol, ibuprofen, hydration, anti-pyretics, analgesics
  • Add Corticosteroid if upper airway obstruction or haemolytic anaemia - Prednisolone
  • Add IVIG on top of Corticosteroids if thrombocytopaenia - Prednisolone / Methylprednisolone/ Dexamethasone + IG Human
22
Q

Identify the possible complications of infectious mononucleosis and its management.

A
  • Upper airway obstruction
  • Splenic rupture
  • Fulminant hepatitis
  • Encephalitis
  • Severe thrombocytopaenia
  • Haemolytic anaemia
  • Long-term fatigue & lethargy
23
Q

Summarise the prognosis for patients with infectious mononucleosis.

A

Most people with mono recover completely with no long-term problems. The fatigue associated with the condition may persist for a few months after the fever and other symptoms have resolved. Severe complications as described above are very rare.

24
Q

Define Meniere’s disease.

A

An auditory disease characterized by an episodic sudden onset of vertigo, low-frequency hearing loss (early stages), low-frequency roaring tinnitus and sensation of fullness in affected ear.

Usually the terms are used interchangeably, but MD is commonly used if it is idiopathic (i.e., without known cause) and Meniere syndrome if it is secondary to a number of known inner-ear disorders.

AKA = Endolymphatic hydrops - due to pathological state observed on post-mortum.

25
Q

Explain the aetiology / risk factors of Meniere’s disease.

A

The cause is unknown, but results in an over-production or impaired absorption of endolymph in the inner ear.

Risk Factors:

  • Recent viral infection with haematogenous spread or direct spread through round window membrane - middle-ear infection, URTI
  • Genetic predisposition - 10-50% of cases, autosomal dominant pattern, X-linked inheritance, HLA-DR, HLA-DQ, HLA-DP
  • Autoimmune disease - e.g. vasculitis, RA, lupus
26
Q

Summarise the epidemiology of Meniere’s disease.

A

The worldwide incidence of Meniere’s disease is approximately 12 out of every 1,000 people. Perhaps 100,000 patients develop Meniere’s disease every year. The overall number affected is about 0.2% of U.S. citizens, a figure of about 615,000 individuals.

27
Q

Recognise the presenting symptoms of Meniere’s disease

A
  • Presence of risk factors - family history, recent viral illness, autoimmune disorders
  • Vertigo
  • Nausea & Vomiting
  • Hearing loss -
  • Tinnitus
  • Aural fullness increasing prior to attack
  • Drop attacks - sudden loss of balance without loss of consciousness or other autonomic or neurological symptoms
28
Q

Recognise the signs of Meniere’s disease on physical examination.

A
  • Positive Romberg’s test - swaying or falling when asked to stand with feet together and eyes closed
  • Fukuda’s stepping test - turning towards the affected side when asked to march in place with eyes closed
  • Nystagmus - horizontal and/or rotatory suppressed by visual fixation
  • Tandem walk - inability to walk (heel-to-toe) in a straight line
29
Q

Identify appropriate investigations for Meniere’s disease and interpret the results.

A

1st Line:
- Pure-tone air and bone conduction with masking - the measurement of hearing sensitivity and integrity of the auditory receptive pathway = unilateral sensorineural hearing loss, low-frequency (early stage, during or before attacks, affects middle and high in late stage)

  • Speech audiometry - no discrepancies on SRT, absence of positive roll-over index
  • Tympanometry / immitance / stapedial reflex levels - normal tympanogram, elicitation of acoustic reflex < 60dB patient threshold; no abnormal reflex decay
  • Oto-acoustic emissions (OAE)- the absence of measurable OAE in frequency range affected by MD

2nd Line:

  • Electrochleography - abnormally large summating potential amplitude relative to action potential amplitude
  • Electronystagmography - abnormal in MD, unilateral decreased vestibular response to affected ear
  • Rotary chair test - decreased gain, abnormal phase and asymmetry in response
  • Vestibular-evoked myogenic potential (VEMP) - increased amplitude (early disease), attenuated or absent (later disease)
  • MRI of internal auditory canals - normal (exclude retrocochlear cause - e.g. acoustic neuroma)
  • TFTs - normal in MD, check if TSH or low T4 cause loss
  • Lyme disease and syphilis serology - exclusion
  • Anti-nuclear antibody - positive in presence of autoimmune pathology
  • Anti-neutrophil cytoplasmic antibody - associated with vasculitis
  • Rheumatoid factor - positive in presence of autoimmune pathology
  • 3D MRI - perilymphatic space surrounding the endolymph is small or unable to be visualised
30
Q

Define thyroglossal cysts.

A

A thyroglossal cyst is a fibrous cyst that forms from a persistent thyroglossal duct.

31
Q

Explain the aetiology / risk factors of thyroglossal cysts.

A

Thyroglossal Duct Cysts are a birth defect. During embryonic development, the thyroid gland is being formed, beginning at the base of the tongue and moving towards the neck canal, known as the thyroglossal duct. Once the thyroid reaches its final position in the neck, the duct normally disappears. In some individuals, portions of the duct remain behind, leaving small pockets, known as cysts. During a person’s life, these cyst pockets can fill with fluids and mucus, enlarging when infected, presenting the thyroglossal cyst.

Develop at birth.

Attached to tongue via tract of thyroid descent.

Up to half of thyroglossal cysts are not diagnosed until adult life. The tract can lie dormant for years or even decades, until some kind of stimulus leads to cystic dilation. Infection can sometimes cause the transient appearance of a mass or enlargement of the cyst, at times with periodic recurrences.

32
Q

Summarise the epidemiology of thyroglossal cysts.

A

Most common cause of midline neck masses.

DDx:

  • Lymphadenopathy
  • Dermoid cysts
  • Odontogenic anomalies
  • Ectopic thyroid
  • Goiter
33
Q

Recognise the presenting symptoms of thyroglossal cysts.

A
  • Irregular neck mass or lump
  • Asymptomatic, painless
  • Neck or throat pain (if infected)
  • Dysphagia
  • Dyspepsia - discomfort in upper abdomen
  • Difficulty breathing
34
Q

Recognise the signs of thyroglossal cysts on physical examination.

A
  • Irregular neck mass or lump located below the hyoid bone
  • Anywhere along path of thyroglossal duct from base of tongue to suprasternal notch
  • Moves on swallowing (attachment to foramen caecum)
  • Moves on protrusion of tongue (attachment to embryonic duct)
  • Smooth and cystic lump
35
Q

Identify appropriate investigations for thyroglossal cysts and interpret the results.

A
  • Bloods - TFTs - check if thyroid function disrupted (goiter, ectopic thyroid)
  • Ultrasound - capture degree of mass and surrounding tissues
  • Thyroid Scan - radioactive iodine or technetium
  • Fine Needle Aspiration - removal of cells for biopsy
36
Q

Define tonsillitis.

A

An acute infection of the parenchyma of the palatine tonsils.

DOES NOT INCLUDE TONSILLITIS AS PART OF INFECTIOUS MONONUCLEOSIS.

May occur in isolation or as part of generalised pharyngitis.

37
Q

Explain the aetiology / risk factors of tonsillitis.

A

Difficult to distinguish clinically from viral pharyngitis.

The most common bacterium causing tonsillitis is Streptococcus pyogenes (group A streptococcus), the bacterium that causes strep throat. Other strains of strep and other bacteria also may cause tonsillitis.

Risk factors:

  • Age between 5-15 years
  • Contact with infected people in enclosed spaces - e.g. child care centres, schools, prison
38
Q

Summarise the epidemiology of tonsillitis.

A

The incidence of tonsillitis is not completely known, research indicates that 15-30% of sore throats in children and 5-10% sore throats in adults are bacterial tonsillitis.

39
Q

Recognise the presenting symptoms of tonsillitis.

A
  • Presence of risk factors
  • Pain on swallowing
  • Sudden onset of sore throat
  • Headache
  • Abdominal pain
  • Nausea & vomiting
40
Q

Recognise the signs of tonsillitis on physical examination.

A
  • Fever - >38 degrees
  • Tonsillar exudate (purulent), especially in Group A B-haemolytic streptococci
  • Abdominal pain - may lead to false diagnosis of gastroenteritis
  • Presence of cough or runny nose
  • Tonsillar erythema
  • Tonsillar enlargement
  • Enlarged anterior cervical lymph nodes especially in Group A B-haemolytic streptococci
41
Q

Identify appropriate investigations for tonsillitis and interpret the results.

A

CENTOR CRITERIA

42
Q

Identify appropriate investigations for tonsillitis and interpret the results.

A

CENTOR CRITERIA

Centor criteria (fever >38.5°C, swollen, tender anterior cervical lymph nodes, tonsillar exudate and absence of cough) are an algorithm to assess the probability of group A β haemolytic Streptococcus (GABHS) as the origin of sore throat, developed for adults.

1st line:
- Throat culture (48hr delay)

  • Rapid streptococcal antigen test - identifies Group A Beta-haemolytic streptococci (GABHS)

2nd line:
- Serological testing for streptococci - x4 increase in Anti-streptolysin O (ASO), anti-deoxyribonuclease B or other antibody titres (hyaluronidase, streptokinase, nicotinic acid dehydrogenase)

  • WBC count and differential - raised neutrophil (bacterial infection) / lymphocytes count (infectious mononucleosis)
  • Heterophile antibodies
  • Vaginal and cervical, or penile and rectal cultures - positive culture (Thayer-Martin medium) for Neisseria gonorrhoea
  • HIV viral load assay - in high-risk patients with persistent infection and severe constitutional symptoms (malaise, tiredness, weight loss, generalised lymphadenopathy)
  • Lateral cervical view X-ray, exposed for soft tissue - enlarged retropharyngeal and posterior oropharyngeal soft tissue